It is not approved by the FDA and is not intended for human or animal consumption, nor for diagnostic, therapeutic, or clinical applications
Chemically Characterized : Each peptide undergoes rigorous analytical verification, including HPLC purification, mass spectrometry confirmation, and chromatographic purity assessment to ensure lot-specific quality documentation
CRS is reportedly present in 51% of patients with COPD and 45-77% of patients with bronchiectasis (127, 130)
These markers collectively offer a comprehensive evaluation of liver health, making them essential for monitoring therapeutic outcomes in chronic hepatitis B
However, there is a 1020% treatment failure rate, at least in part due to antibiotic resistance
[DOI] [PMC free article] [PubMed] [Google Scholar] 152.McKay T.B., Sarker-Nag A., Lyon D., Asara J.M., Karamichos D